Baliakas P

Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML.

Nyquist OE, Dalgaard J, Spetalen S, ..., Baliakas P, Dybedal I

Br. J. Haematol. - (-) - [2023-11-28; online 2023-11-28]

Clinical Genomics Uppsala [Collaborative]

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.

Eriksson A, Engvall M, Mathot L, ..., Ladenvall C, Baliakas P

Clin. Cancer Res. 29 (15) 2826-2834 [2023-08-01; online 2023-04-07]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics Uppsala [Collaborative] NGI Short read [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib.

Bonfiglio S, Sutton LA, Ljungström V, ..., Rosenquist R, Ghia P

Blood Adv 7 (12) 2794-2806 [2023-06-27; online 2023-01-26]

Clinical Genomics Uppsala [Collaborative]

Early response evaluation by single cell signaling profiling in acute myeloid leukemia.

Tislevoll BS, Hellesøy M, Fagerholt OHE, ..., Blaser N, Gjertsen BT

Nat Commun 14 (1) 115 [2023-01-07; online 2023-01-07]

Clinical Genomics Uppsala [Service]

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.

Voso MT, Pandzic T, Falconi G, ..., Fabiani E, Baliakas P

Br. J. Haematol. 198 (1) 103-113 [2022-07-00; online 2022-03-11]

Clinical Genomics Uppsala [Service]

Loss of Y and clonal hematopoiesis in blood-two sides of the same coin?

Ljungström V, Mattisson J, Halvardson J, ..., Baliakas P, Forsberg LA

Leukemia 36 (3) 889-891 [2022-03-00; online 2021-11-01]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics Uppsala [Service] NGI SNP genotyping [Service] NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome.

Amini RM, Ljungström V, Abdulla M, ..., Enblad G, Baliakas P

Am. J. Hematol. 95 (10) - [2020-07-06; online 2020-07-06]

Clinical Genomics Uppsala [Collaborative]